Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia

被引:240
作者
Palareti, G
Legnani, C
Cosmi, B
Valdré, L
Lunghi, B
Bernardi, F
Coccheri, S
机构
[1] Univ Hosp S Orsola Malpighi, Dept Angiol, Unita Ric Clin Trombofilia Marino Golinelli, I-40138 Bologna, Italy
[2] Univ Ferrara, Dept Biochim & Biol Mol, I-44100 Ferrara, Italy
关键词
thrombophilia; fibrin fibrinogen degradation product; thromboembolism; thrombosis;
D O I
10.1161/01.CIR.0000079162.69615.0F
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-We have shown that normal D-dimer levels obtained after the discontinuation of oral anticoagulant treatment (OAT) has a high negative predictive value for recurrent venous thromboembolism (VTE). The aim of the present study was to assess the predictive value of D-dimer for recurrent VTE in subjects with a previous unprovoked event who are either carriers of inherited thrombophilia or not. Methods and Results-We prospectively evaluated 599 patients (301 males) with a previous VTE episode. They were repeatedly examined for D-dimer levels after OAT withdrawal and were screened for inherited thrombophilic alterations. Alterations were detected in 130 patients (21.7%), factor V Leiden (70 patients; 2 of whom were homozygotes) and prothrombin mutation (38 patients) were the most prevalent ones. Recurrent events were recorded in 58 subjects (9.7%) during a follow-up of 870.7 patient-years. Altered D-dimer levels at 1 month after OAT withdrawal were associated with a higher rate of subsequent recurrence in all subjects investigated, especially in those with an unprovoked qualifying VTE event (hazard ratio, 2.43; 95% confidence interval, 1.18 to 4.61) and in those with thrombophilia (hazard ratio, 8.34; 95% confidence interval, 2.72 to 17.43). The higher relative risk for recurrence of altered D-dimer was confirmed by multivariate analysis after adjustment for other risk factors. The negative predictive value of D-dimer was 92.9% and 95.8% in subjects with an unprovoked qualifying event or with thrombophilia, respectively. Conclusions-D-dimer levels measured 1 month after OAT withdrawal have a high negative predictive value for recurrence in subjects with unprovoked VTE who are either carriers or not carriers of congenital thrombophilia.
引用
收藏
页码:313 / 318
页数:6
相关论文
共 24 条
[1]   Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. [J].
Agnelli, G ;
Prandoni, P ;
Santamaria, MG ;
Bagatella, P ;
Iorio, A ;
Bazzan, M ;
Moia, M ;
Guazzaloca, G ;
Bertoldi, A ;
Tomasi, C ;
Scannapieco, G ;
Ageno, W ;
Ascani, A ;
Villalta, S ;
Frulla, M ;
Mosena, L ;
Girolami, A ;
Vaccarino, A ;
Alatri, A ;
Palareti, G ;
Marchesi, M ;
Ambrosio, GB ;
Parisi, R ;
Doria, S ;
Steidl, L ;
Ambrosini, F ;
Silingardi, M ;
Ghirarduzzi, A ;
Iori, I .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) :165-169
[2]   The thrombophilias: Well-defined risk factors with uncertain therapeutic implications [J].
Bauer, KA .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (05) :367-373
[3]   The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation [J].
De Stefano, V ;
Martinelli, I ;
Mannucci, PM ;
Paciaroni, K ;
Chiusolo, P ;
Casorelli, I ;
Rossi, E ;
Leone, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (11) :801-806
[4]   Risk of fatal pulmonary embolism in patients with treated venous thromboembolism [J].
Douketis, JD ;
Kearon, C ;
Bates, S ;
Duku, EK ;
Ginsberg, JS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (06) :458-462
[5]  
Eichinger S, 1997, THROMB HAEMOSTASIS, V77, P624
[6]  
Emmerich J, 1997, THROMB HAEMOSTASIS, V77, P620
[7]   Antithrombotic therapy for venous thromboembolic disease [J].
Hyers, TM ;
Agnelli, G ;
Hull, RD ;
Morris, TA ;
Samama, M ;
Tapson, V ;
Weg, JG .
CHEST, 2001, 119 (01) :176S-193S
[8]   A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism [J].
Kearon, C ;
Gent, M ;
Hirsh, J ;
Weitz, J ;
Kovacs, MJ ;
Anderson, DR ;
Turpie, AG ;
Green, D ;
Ginsberg, JS ;
Wells, P ;
MacKinnon, B ;
Julian, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (12) :901-907
[9]   Management of patients with hereditary hypercoagulable disorders [J].
Kearon, C ;
Crowther, M ;
Hirsh, J .
ANNUAL REVIEW OF MEDICINE, 2000, 51 :169-185
[10]   High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. [J].
Kyrle, PA ;
Minar, E ;
Hirschl, M ;
Bialonczyk, C ;
Stain, M ;
Schneider, B ;
Weltermann, A ;
Speiser, W ;
Lechner, K ;
Eichinger, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (07) :457-462